RecruitingNCT03146884
Swiss Autoimmune Hepatitis Cohort Study
Sponsor
Fondazione Epatocentro Ticino
Enrollment
500 participants
Start Date
Feb 16, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
Research project in which biological material is sampled and health-related personal data is further used and collected. Coded data are used.
Eligibility
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with autoimmune hepatitis and hepatitis, autoimmune. The study is currently recruiting participants at 20 locations.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(20)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03146884
Related Trials
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
NCT031786301 location
MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
NCT031754711 location
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
NCT057504988 locations
PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G
NCT058104806 locations
Host-Diet-Gut Interaction Post Vegan Diet in Pediatric Autoimmune Hepatitis.
NCT071186571 location